Open AccessEffects of liraglutide compared with placebo on events of acute gallbladder or biliary disease in patients with type 2 diabetes at high risk for cardiovascular events in the LEADER randomized trial. Diabetes Care 2019;42:1912-1920
Author(s) -
M.A. Nauck,
E. Kreiner,
S. Rasmussen,
H.A. Saevereid,
J.B. Buse
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/hmrw-yb89
Subject(s) - liraglutide , medicine , type 2 diabetes , diabetes mellitus , placebo , randomized controlled trial , disease , gastroenterology , biliary disease , endocrinology , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom